Skip to main content
Top
Metadata
Title
Beyond the genetic lesions: gene inactivation by promoter hypermethylation in human cancer
Publication date
01-03-2000
Published in
Clinical and Translational Oncology / Issue 2/2000
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02979467

Other articles of this Issue 2/2000

Clinical and Translational Oncology 2/2000 Go to the issue

Announcement

Información

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine